[
    [
        {
            "time": "",
            "original_text": "医药生物行业：第四批集采落地 建议上游原料药行业",
            "features": {
                "keywords": [
                    "医药生物",
                    "第四批集采",
                    "上游原料药"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物",
                    "原料药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "医药生物行业：第四批集采落地 建议上游原料药行业",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股多数反弹，健帆生物、泰格、恩捷、甘李药业、凯莱英飘红",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "反弹",
                    "健帆生物",
                    "泰格",
                    "恩捷",
                    "甘李药业",
                    "凯莱英"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "高瓴资本概念股多数反弹，健帆生物、泰格、恩捷、甘李药业、凯莱英飘红",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]